-Reuters
Cassava Sciences Releases a Public Statement Regarding Recent Allegations
Cassava Sciences, Inc. (NASDAQ:SAVA), a biotechnology company focused on Alzheimer's disease, today released a public statement regarding recent allegations made against the Company.
"Let me be very